Pro Medicus Limited (PMCUF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Pro Medicus Limited's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
259.16
Weak
WeakModerateStrong
P/B Ratio
115.91
Weak
WeakModerateStrong
Earnings Yield
0.39%
Yield Trap
WeakModerateStrong
Profitability Health
2025Return on Equity
44.84%
Strong
WeakModerateStrong
Operating Margin
74.03%
Strong
WeakModerateStrong
Net Profit Margin
54.12%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
31.83%
Strong
WeakModerateStrong
Net Income Growth
39.16%
Strong
WeakModerateStrong
EPS Growth
39.24%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
6.49
Strong
WeakModerateStrong
Quick Ratio
6.49
Strong
WeakModerateStrong
Asset Turnover
0.63x
Moderate
WeakModerateStrong
Inventory Turnover
3.15x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
0.35%
Weak
WeakModerateStrong
EV / Free Cash Flow
284.85x
Weak
WeakModerateStrong
Net Debt / EBITDA
-1.05x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.036
Strong
WeakModerateStrong
Return on Invested Capital
37.45%
Strong
WeakModerateStrong
Cash Conversion Cycle
-1436.11 days
Strong
WeakModerateStrong
Fortress screener guardrails
3/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for PMCUF.
View Financial Statements